Full-Time

Associate Director

Portfolio Operations

Confirmed live in the last 24 hours

Voyager Therapeutics

Voyager Therapeutics

51-200 employees

Gene therapy and neurology advancement platform

Biotechnology

Senior

Lexington, MA, USA

Requirements
  • Bachelor's degree in science, business, or related field required; MBA or advanced degree preferred. Preference for candidates with an education in both science and business.
  • Minimum of 10 years of progressive experience with minimum of 3+ years spent in program management, portfolio management, R&D Operations, or related field.
  • Must understand drug development stage gates, including preclinical, clinical phases, and regulatory milestones.
  • Strong understanding of financial markets, investment principles, portfolio optimization strategies, and risk management techniques.
  • Demonstrated leadership abilities, including experience fostering a collaborative and inclusive work environment.
  • Excellent analytical and quantitative skills, with the ability to interpret complex data, perform modeling, and make informed decisions.
  • Effective communication skills, both verbal and written, with the ability to articulate complex concepts clearly and concisely to diverse audiences, including senior management, stakeholders, and external partners.
  • Familiarity with regulatory requirements and compliance standards relevant to portfolio management, including SEC regulations and industry best practices.
  • Proven ability to thrive in a fast-paced, dynamic environment, with a high level of adaptability, flexibility, and resilience to changing priorities and business needs.
  • Strong attention to detail and a commitment to accuracy and precision in all aspects of work, including financial analysis, reporting, and documentation.
  • Ability to collaborate effectively with cross-functional teams, including research and development, finance, legal, and external partners, to achieve common goals and drive results.
  • Passion for Voyager Therapeutics' mission to develop transformative gene therapies for patients with severe neurological diseases, and a desire to make a meaningful impact in the field of biotechnology.
Responsibilities
  • Manage and oversee Voyager Therapeutics' portfolio operations, in alignment with the company's overall goals and objectives.
  • Generate regular reports/communications that summarize portfolio metrics, issues and documents/presentations for governance forums, senior management and Board of Directors
  • Manage R&D governance in a stage-appropriate manner to implement needed disciplines while preserving the agility and flexibility of a fast-growing biotech company.
  • Serve as R&D Lead and Partner with Finance to develop, manage, and track AOP and budget activities for Research and Development.
  • Liaise with Business Development on potential opportunities and program-specific competitive intelligence.
  • Partner with Program/Product Leader/PMs to shape program strategy and execution plan for assigned programs.
  • Build relationships with key stakeholders (team members and leadership) to ensure alignment of program plans with functional and corporate objectives.
  • Prepare program status update and presentations for appropriate governance bodies
  • Partner with the Finance team to develop and track portfolio budget.
  • Proactively identify and escalate gaps and challenges; managing team through scenario planning to solve problems.
  • Support development and scaling of stage-appropriate capabilities, tools, and processes as the company’s portfolio continues to grow.

Voyager Therapeutics is an ideal workplace for those passionate about groundbreaking developments in gene therapy and neurology. The company's focus on its proprietary TRACER™ AAV capsid discovery platform allows for the creation of innovative treatments with enhanced delivery mechanisms, specifically targeting challenging diseases like Alzheimer's, ALS, and Parkinson’s. This commitment to technological advancement, coupled with significant collaborations with leading pharmaceutical companies, positions it as a leader in neuroscience research and development.

Company Stage

IPO

Total Funding

$344M

Headquarters

Cambridge, Massachusetts

Founded

2014

Growth & Insights
Headcount

6 month growth

7%

1 year growth

32%

2 year growth

47%